Author details

Full Name

Suchit Jhunjhunwala

Affiliation

Genentech Inc.

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

Trey Ideker (CM4AI)

PMID	Paper Title	Journal Title	Published Year
37027981	The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens.	Semin Immunol	2023
37487664	Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming.	J Immunother Cancer	2023
37741832	Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.	Nat Commun	2023
36418317	Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.	Nat Commun	2022
32940337	In silico tools for accurate HLA and KIR inference from clinical sequencing data empower immunogenetics on individual-patient and population scales.	Brief Bioinform	2021
33750922	Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion.	Nat Rev Cancer	2021
33936100	An Integrated Genomic, Proteomic, and Immunopeptidomic Approach to Discover Treatment-Induced Neoantigens.	Front Immunol	2021
34172722	Molecular determinants of response to PD-L1 blockade across tumor types.	Nat Commun	2021
32391432	Cancer neoantigens and immunogenicity: mutation position matters.	Mol Cell Oncol	2020
31940002	Mutation position is an important determinant for predicting cancer neoantigens.	J Exp Med	2020
30943407	Regulation of Tumor-Associated Myeloid Cell Activity by CBP/EP300 Bromodomain Modulation of H3K27 Acetylation.	Cell Rep	2019
31745090	Transposable element expression in tumors is associated with immune infiltration and increased antigenicity.	Nat Commun	2019
31511069	Late-differentiated effector neoantigen-specific CD8+ T cells are enriched in peripheral blood of non-small cell lung carcinoma patients responding to atezolizumab treatment.	J Immunother Cancer	2019
29229751	SUV420H2 is an epigenetic regulator of epithelial/mesenchymal states in pancreatic cancer.	J Cell Biol	2018
29867230	Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.	Nat Med	2018
30291359	Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.	Nat Med	2018
29443960	TGFÎ² attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.	Nature	2018
27928884	Building proteomic tool boxes to monitor MHC class I and class II peptides.	Proteomics	2017
28478383	Characterizing neoantigens for personalized cancer immunotherapy.	Curr Opin Immunol	2017
28781121	Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure.	Cancer Cell	2017
27875550	An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition.	PLoS One	2016
26384565	Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci.	Nucleic Acids Res	2016
25840969	A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.	Clin Cancer Res	2015
24807215	Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.	Nat Commun	2014
25428506	Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.	Nature	2014
25315065	MBASED: allele-specific expression detection in cancer tissues and cell lines.	Genome Biol	2014
25159915	Diverse modes of genomic alteration in hepatocellular carcinoma.	Genome Biol	2014
22108827	Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.	Cancer Res	2012
23033341	Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.	Genome Res	2012
22267523	The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients.	Genome Res	2012
22432722	Complementary proteomic tools for the dissection of apoptotic proteolysis events.	J Proteome Res	2012
21673316	TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer.	Sci Signal	2011
21868360	miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes epithelial-to-mesenchymal transition in breast cancer.	Sci Signal	2011
21903424	Multilineage priming of enhancer repertoires precedes commitment to the B and myeloid cell lineages in hematopoietic progenitors.	Immunity	2011
20543837	A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.	Nat Immunol	2010
19665968	Chromatin architecture and the generation of antigen receptor diversity.	Cell	2009
18423198	The 3D structure of the immunoglobulin heavy-chain locus: implications for long-range genomic interactions.	Cell	2008
11928499	Genome-wide pathway analysis and visualization using gene expression data.	Pac Symp Biocomput	2002

1 - 38 of 38

Tiago da Silva Medina

International Research Center, A.C.Camargo Cancer Center

Career Start Year 2016

Number of shared co-authors 0

Rachel Marty Pyke

University of California San Diego

Career Start Year 2016

Number of shared co-authors 1

Megan M Richters

Washington University School of Medicine

Career Start Year 2016

Number of shared co-authors 0

Reyka G Jayasinghe

Washington University in St Louis

Career Start Year 2015

Number of shared co-authors 0

Scott D Brown

BC Cancer Research Institute

Career Start Year 2014

Number of shared co-authors 1

Katie M Campbell

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 2014

Number of shared co-authors 0

Tao Wang

University of Texas Southwestern Medical Center

Career Start Year 2014

Number of shared co-authors 2

Ang Cui

Massachusetts Institute of Technology

Career Start Year 2013

Number of shared co-authors 1

Laurie Tonon

Cancer Research Center of Lyon, UMR INSERM 2, CNRS 5286

Career Start Year 2010

Number of shared co-authors 0

Jasreet Hundal

McDonnell Genome Institute, Washington University School of Medicine

Career Start Year 2010

Number of shared co-authors 0

Benjamin G Barwick

Emory University School of Medicine

Career Start Year 2009

Number of shared co-authors 1

Ganiraju C Manyam

the University of Texas MD Anderson Cancer Center

Career Start Year 2009

Number of shared co-authors 0

Hannah Carter

University of California San Diego

Career Start Year 2008

Number of shared co-authors 2

Benjamin G Vincent

UNC School of Medicine, The University of North Carolina at Chapel Hill

Career Start Year 2008

Number of shared co-authors 1

Riyue Bao

UPMC Hillman Cancer Center

Career Start Year 2007

Number of shared co-authors 1

Samuel S Freeman

St Vincent's Hospital Melbourne

Career Start Year 2006

Number of shared co-authors 0

Linghua Wang

The University of Texas M. D. Anderson

Career Start Year 2006

Number of shared co-authors 2

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Ansuman T Satpathy

Stanford University

Career Start Year 2005

Number of shared co-authors 2

Fengshen Kuo

Memorial Sloan Kettering Cancer Center

Career Start Year 2003

Number of shared co-authors 1

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 0

Malachi Griffith

Washington University

Career Start Year 2003

Number of shared co-authors 1

Jianhua Zhang

University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 3

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 2

Vladimir Makarov

Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic

Career Start Year 2001

Number of shared co-authors 1

Ludmila Danilova

Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine

Career Start Year 2001

Number of shared co-authors 1

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 1

Timothy A Chan

Cleveland Clinic.

Career Start Year 1994

Number of shared co-authors 3

Nir Hacohen

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 6

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 5

row(s) 1 - 30 of 30